Christina Escobar, MD
Urogynecology and Reconstructive Pelvic Surgery · New York, NYNPI 1346651890
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $11,661 with a category attached, or 85.8%. Medtronic accounts for 91.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $10,086 and has fallen 98.8% since, to $125 in 2025.
Across 40 payments — averaging $291.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Boston Scientific$283
- AbbVie$191
- Johnson & Johnson$75
- ABC Home Medical Supply, Inc.$74
- Coopersurgical, Inc.$69
- plus $301 from 9 others
What the payments were for
- Grants$10,00086%
- Food & beverage$1,61214%
- Education$480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 8 | $10,668 |
| Boston Scientific | 2 | $283 |
| AbbVie | 9 | $191 |
| Johnson & Johnson | 3 | $75 |
| ABC Home Medical Supply, Inc. | 3 | $74 |
| Coopersurgical, Inc. | 3 | $69 |
| Applied Medical Resources Corporation | 1 | $63 |
| Axonics, Inc. | 1 | $56 |
| Astellas Pharma US Inc | 3 | $51 |
| Pfizer | 2 | $42 |
| Novo Nordisk | 1 | $24 |
| Millicent US Inc | 1 | $20 |
| Hollister Incorporated | 1 | $19 |
| Dentsply IH Inc. | 1 | $16 |
| Intuitive Surgical | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$10,521
- Advantage System$147
- UPSYLON$136
How this compares
$11,661 in reported general payments places this provider in the 85th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.
See all urogynecology and reconstructive pelvic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 48 | $34,814 |
| MyrbetriqMirabegron | 35 | $21,533 |
| EstringEstradiol | 21 | $10,636 |
| Estradiol | 104 | $6,249 |
| ImvexxyEstradiol | 12 | $5,211 |
| Solifenacin Succinate | 28 | $2,921 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $331 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $51 | $21,53335 claims |
| PfizerEstring | $42 | $10,63621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.
Other urogynecology and reconstructive pelvic surgery in New York
- Ido SirotaNew York$12K
- Kimberly FerranteNew York$11K
- Alan GarelyNew York$7K
- Larissa RodriguezNew York$5K
- Melissa LaudanoNew York$4K
- Feven GetanehNew York$4K
- Chandhana PakaNew York$4K
- Svjetlana LozoNew York$2K
- Lisa DabneyNew York$2K
- Matan MekaytenNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.